HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sagar Lonial Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

2/2015Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
11/2011Current advances in novel proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myeloma.
9/2007Maintenance therapy in lymphoma.
10/2006Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sagar Lonial Research Topics

Disease

216Multiple Myeloma
12/2023 - 01/2003
69Neoplasms (Cancer)
09/2023 - 01/2004
16Peripheral Nervous System Diseases (PNS Diseases)
01/2023 - 01/2006
13Lymphoma (Lymphomas)
01/2016 - 12/2004
11Fatigue
09/2023 - 08/2010
10Disease Progression
01/2022 - 06/2005
10Thrombocytopenia (Thrombopenia)
01/2020 - 12/2005
9Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 02/2002
9Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2015 - 10/2006
8Neutropenia
01/2023 - 11/2007
7Infections
01/2023 - 02/2002
5Chromosome Aberrations (Chromosome Abnormalities)
12/2023 - 09/2015
5Residual Neoplasm
01/2021 - 01/2003
5Diarrhea
01/2020 - 01/2017
5Graft vs Host Disease (Graft-Versus-Host Disease)
10/2008 - 07/2003
4Sepsis (Septicemia)
11/2022 - 01/2017
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 04/2009
4Renal Insufficiency (Renal Failure)
01/2018 - 03/2007
4Melanoma (Melanoma, Malignant)
01/2018 - 01/2004
4Leukemia
01/2016 - 10/2003
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2015 - 10/2006
3Tetanus
03/2024 - 12/2002
3Human Influenza (Influenza)
03/2024 - 12/2002
3Cytokine Release Syndrome
12/2023 - 01/2019
3Pain (Aches)
09/2023 - 06/2014
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2021 - 06/2008
3Myocarditis (Carditis)
09/2019 - 01/2018
3Castleman Disease (Castleman's Disease)
01/2016 - 08/2010
3Lung Neoplasms (Lung Cancer)
07/2007 - 05/2007
2Plasmacytoma
09/2023 - 01/2017

Drug/Important Bio-Agent (IBA)

66Bortezomib (Velcade)FDA Link
11/2023 - 06/2005
58Dexamethasone (Maxidex)FDA LinkGeneric
11/2023 - 06/2005
44Lenalidomide (CC 5013)FDA Link
11/2023 - 10/2007
35Proteasome InhibitorsIBA
12/2023 - 12/2005
26Monoclonal AntibodiesIBA
11/2023 - 01/2006
22daratumumabIBA
01/2022 - 01/2016
17Proteins (Proteins, Gene)FDA Link
09/2023 - 07/2007
16Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020 - 04/2006
14Immunomodulating AgentsIBA
11/2023 - 06/2009
14carfilzomibIBA
10/2021 - 06/2011
14PanobinostatIBA
01/2021 - 05/2012
11Thalidomide (Thalomid)FDA Link
01/2023 - 05/2006
10ixazomibIBA
12/2023 - 08/2014
10elotuzumabIBA
06/2022 - 06/2012
9belantamab mafodotinIBA
12/2023 - 01/2020
9pomalidomideIBA
09/2023 - 03/2014
8Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 05/2010
7Immunoglobulins (Immunoglobulin)IBA
02/2022 - 04/2011
7Immunoconjugates (Immunoconjugate)IBA
11/2021 - 01/2019
7Cisplatin (Platino)FDA LinkGeneric
01/2020 - 10/2006
7CytokinesIBA
01/2019 - 01/2004
7EnzymesIBA
01/2019 - 12/2011
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2015 - 12/2004
6VaccinesIBA
01/2023 - 03/2008
6selinexorIBA
02/2021 - 01/2019
6Prednisone (Sone)FDA LinkGeneric
01/2018 - 09/2007
6Rituximab (Mabthera)FDA Link
11/2015 - 09/2007
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 09/2007
6Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2015 - 12/2002
5Chimeric Antigen ReceptorsIBA
05/2023 - 01/2019
5Biomarkers (Surrogate Marker)IBA
10/2021 - 09/2013
5Vincristine (Oncovin)FDA LinkGeneric
11/2015 - 10/2006
4B-Cell Maturation AntigenIBA
09/2023 - 01/2020
4AntigensIBA
01/2023 - 12/2002
4AntibodiesIBA
01/2022 - 12/2002
4venetoclaxIBA
01/2021 - 01/2019
4Histone Deacetylase InhibitorsIBA
12/2020 - 05/2012
4Phosphotransferases (Kinase)IBA
01/2020 - 12/2011
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 07/2007
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015 - 09/2007
4plerixaforFDA Link
10/2015 - 10/2011
3mRNA VaccinesIBA
03/2024 - 01/2023
3RNA (Ribonucleic Acid)IBA
01/2021 - 11/2015
3EverolimusFDA Link
10/2020 - 01/2019
3PlatinumIBA
01/2020 - 01/2018
3acetoacetic acid (acetoacetate)IBA
01/2017 - 08/2015
3Histone Deacetylases (Histone Deacetylase)IBA
01/2017 - 09/2010
3Epidermal Growth Factor (EGF)IBA
12/2016 - 02/2014
3siltuximabIBA
01/2016 - 08/2010
3fludarabineIBA
09/2015 - 10/2003
3liposomal doxorubicin (Doxil)FDA Link
09/2014 - 05/2010
3Etoposide (VP 16)FDA LinkGeneric
06/2014 - 10/2006
3Cytarabine (Cytosar-U)FDA LinkGeneric
12/2013 - 10/2006
3Tyrosine (L-Tyrosine)FDA Link
12/2011 - 11/2009
2Immunoglobulin G (IgG)IBA
03/2024 - 03/2024
2Drug CombinationsIBA
09/2023 - 09/2014
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
09/2023 - 01/2023
2idecabtagene vicleucelIBA
01/2023 - 01/2021

Therapy/Procedure

118Therapeutics
12/2023 - 01/2003
14Stem Cell Transplantation
06/2022 - 08/2009
14Transplantation
06/2022 - 02/2002
13Drug Therapy (Chemotherapy)
01/2019 - 12/2004
9Immunotherapy
01/2023 - 01/2003
5Cell Transplantation
12/2015 - 08/2011
4Hematopoietic Stem Cell Transplantation
01/2016 - 03/2014
4Blood Component Removal (Apheresis)
10/2015 - 12/2004
4Hematopoietic Stem Cell Mobilization
09/2013 - 10/2006
3Radiotherapy
12/2020 - 01/2016
3Salvage Therapy
12/2020 - 10/2006
3Autologous Transplantation
04/2015 - 10/2006